ProfileGDS5678 / 1459128_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 60% 59% 59% 58% 58% 60% 60% 59% 58% 58% 59% 58% 59% 59% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.6419760
GSM967853U87-EV human glioblastoma xenograft - Control 23.5211859
GSM967854U87-EV human glioblastoma xenograft - Control 33.5271659
GSM967855U87-EV human glioblastoma xenograft - Control 43.4302458
GSM967856U87-EV human glioblastoma xenograft - Control 53.4669258
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.6585960
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6780260
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.5217259
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4633658
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4864958
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.5231659
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4570958
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5670359
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.5275359